CenterBook Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10,534
| Closed | -$932K | – | 397 |
|
|
2023
Q3 | $932K | Sell |
10,534
-2,776
| -21% | -$246K | 0.12% | 257 |
|
|
2023
Q2 | $1.15M | Buy |
13,310
+4,365
| +49% | +$378K | 0.14% | 220 |
|
|
2023
Q1 | $870K | Buy |
8,945
+507
| +6% | +$49.3K | 0.12% | 253 |
|
|
2022
Q4 | $873K | Sell |
8,438
-2,079
| -20% | -$215K | 0.14% | 217 |
|
|
2022
Q3 | $892K | Buy |
10,517
+1,895
| +22% | +$161K | 0.17% | 202 |
|
|
2022
Q2 | $715K | Buy |
8,622
+1,480
| +21% | +$123K | 0.15% | 229 |
|
|
2022
Q1 | $551K | Sell |
7,142
-2,567
| -26% | -$198K | 0.2% | 187 |
|
|
2021
Q4 | $858K | Buy |
+9,709
| New | +$858K | 0.5% | 57 |
|